Dr Earl Michael Chester, MD | |
320 Sunnyview Ln, Kalispell, MT 59901-3129 | |
(406) 751-9729 | |
(406) 751-7521 |
Full Name | Dr Earl Michael Chester |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 15 Years |
Location | 320 Sunnyview Ln, Kalispell, Montana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740418136 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 2014-00691 (North Carolina) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | 47139 (Montana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northern Regional Hospital | Mount airy, NC | Hospital |
Ashe Memorial Hospital | Jefferson, NC | Hospital |
Pioneer Community Hospital Of Stokes | Danbury, NC | Hospital |
Novant Health Forsyth Medical Center | Winston-salem, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Triad Radiology Associates Pllc | 8729086194 | 65 |
News Archive
In research published in the August issue of Free Radical Biology and Medicine, U of T pharmacy and pharmacology professor Peter Wells and his colleagues determined that exposing pregnant mice only once to methamphetamine led to delivery of offspring with long-term neurodevelopmental problems, including reduced motor co-ordination.
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic benefit. Given the type of drug cocktail patients use to treat their HIV, much more or considerably less chemotherapy may be warranted, say the researchers, part of the NCI-supported AIDS Malignancy Consortium (AMC). The trial design is being presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).
Mice that vocalize in a repetitive, halting pattern similar to human stuttering may provide insight into a condition that has perplexed scientists for centuries, according to a new study by researchers at Washington University School of Medicine in St. Louis and the National Institutes of Health.
› Verified 3 days ago
Entity Name | Triad Radiology Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659485001 PECOS PAC ID: 8729086194 Enrollment ID: O20061120000009 |
News Archive
In research published in the August issue of Free Radical Biology and Medicine, U of T pharmacy and pharmacology professor Peter Wells and his colleagues determined that exposing pregnant mice only once to methamphetamine led to delivery of offspring with long-term neurodevelopmental problems, including reduced motor co-ordination.
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic benefit. Given the type of drug cocktail patients use to treat their HIV, much more or considerably less chemotherapy may be warranted, say the researchers, part of the NCI-supported AIDS Malignancy Consortium (AMC). The trial design is being presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).
Mice that vocalize in a repetitive, halting pattern similar to human stuttering may provide insight into a condition that has perplexed scientists for centuries, according to a new study by researchers at Washington University School of Medicine in St. Louis and the National Institutes of Health.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Earl Michael Chester, MD 320 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 751-9729 | Dr Earl Michael Chester, MD 320 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 751-9729 |
News Archive
In research published in the August issue of Free Radical Biology and Medicine, U of T pharmacy and pharmacology professor Peter Wells and his colleagues determined that exposing pregnant mice only once to methamphetamine led to delivery of offspring with long-term neurodevelopmental problems, including reduced motor co-ordination.
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic benefit. Given the type of drug cocktail patients use to treat their HIV, much more or considerably less chemotherapy may be warranted, say the researchers, part of the NCI-supported AIDS Malignancy Consortium (AMC). The trial design is being presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).
Mice that vocalize in a repetitive, halting pattern similar to human stuttering may provide insight into a condition that has perplexed scientists for centuries, according to a new study by researchers at Washington University School of Medicine in St. Louis and the National Institutes of Health.
› Verified 3 days ago
Richard Friedman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 320 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-7519 Fax: 406-751-7529 | |
C. Read Vaughan, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 320 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-7519 Fax: 406-751-7529 | |
Dr. Nick Cade Cantrell, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 320 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-7519 | |
Zachary White Washburn, Radiology Medicare: Accepting Medicare Assignments Practice Location: 320 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-9729 Fax: 406-751-7521 | |
Michael Henson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 320 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-7519 Fax: 406-751-7529 | |
Gordon D. Stillie, D.O. Radiology Medicare: Medicare Enrolled Practice Location: 343 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-1790 | |
D. James Schumacher, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 320 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-7519 Fax: 406-751-7529 |